Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a strong buy rating to the company.

Several equities research analysts have issued reports on the stock. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. Sanford C. Bernstein lowered Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th.

Check Out Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

Shares of OTCMKTS RBGLY opened at $12.13 on Friday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $15.03. The firm’s 50 day moving average price is $12.33 and its 200 day moving average price is $11.72.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

See Also

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.